Bone Mineral Densitometry (BMD) Market is segmented By Product Type, By Technology, By Application, By End-user and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Market Overview
The global bone mineral densitometry (BMD) market reached US$ 326.19 million in 2023 and is expected to reach US$ 452.88 million by 2031, growing at a CAGR of 4.2% during the forecast period 2024-2031.
Bone mineral densitometry (BMD) is a diagnostic technique that measures bone mineral density, which is critical for determining bone health and identifying disorders like osteoporosis. This non-invasive treatment uses low-dose X-rays or dual-energy X-ray absorptiometry (DXA) to measure the quantity of calcium and other minerals in specific bone regions, such as the spine, hip, and forearm. The results are presented as T-scores, which compare a patient's bone density to that of a healthy young adult, allowing healthcare providers to assess the risk of fractures and design suitable treatment strategies.
The increasing prevalence of bone-related diseases is the driving factor that drives the market over the forecast period. For instance, according to the International Osteoporosis Foundation, Osteoporosis is a major noncommunicable disease and the most common bone disease, affecting one in three women and one in five men over the age of 50 globally.
Executive Summary
For more details on this report – Request for Sample
Market Dynamics: Drivers & Restraints
Increasing prevalence of bone-related diseases
The rising burden and increasing prevalence of bone-related disorders is expected to be a significant factor in the growth of the global bone mineral densitometry (BMD) market. Increasing bone-related disorders such as osteoporosis, osteopenia, fractures, and rheumatoid arthritis, along with other diseases are expected to increase the demand for bone density testing for the diagnosis of diseases and drive the global bone mineral densitometry (BMD) market.
For instance, according to the World Health Organization, rheumatoid arthritis affects around 18 million people globally. Women account for around 70% of those with rheumatoid arthritis, with 55% being over the age of 55. Rheumatoid arthritis affects 13 million people, with varying degrees of severity. Moreover, according to the International Osteoporosis Foundation, Osteoporosis is predicted to impact 200 million women worldwide, roughly one-tenth of women aged 60, one-fifth of women aged 70, two-fifths of women aged 80, and two-thirds of women aged 90.
High cost of bone densitometers
The high cost of bone densitometers is challenging as the manufacturing and development of the required components are expensive. These high costs hamper the global bone mineral densitometry (BMD) market. For instance, the basic model of the bone densitometer costs $16,000 and it can range up to $45,000 to $ 90,000 for advanced versions of feature-rich DEXA scanners.
Market Segment Analysis
The global bone mineral densitometry (BMD) market is segmented based on product type, technology, application, end-user, and region.
Technology:
Dual-Energy X-ray Absorptiometry (DEXA) segment is expected to dominate the global bone mineral densitometry (BMD) market share
Dual-Energy X-ray Absorptiometry (DEXA) segment is expected to dominate the global bone mineral densitometry (BMD) market share. Dual-energy X-ray Absorptiometry (DEXA), often known as DXA, is a medical imaging technology that primarily measures bone mineral density (BMD). This non-invasive method directs two separate X-ray beams with varying intensity levels at the patient's bones. DEXA can accurately determine bone density by evaluating the differential absorption of these beams, one absorbed mostly by soft tissue and the other primarily by bone.
The dominance of this segment is due to its established significance as the gold standard for determining bone mineral density. This technology is well-known for its accuracy and reliability in detecting osteoporosis and measuring fracture risk, especially in particular regions like the hip and spine. For instance, according to the National Institute of Health, dual-energy x-ray absorptiometry is comparatively inexpensive, with notably shorter scan times and lower radiation exposure compared to other imaging options.
Quantitative ultrasound segment is the fastest growing segment in the global bone mineral densitometry (BMD) market share
Quantitative ultrasound segment is the fastest growing segment in the global bone mineral densitometry (BMD) market. This is because, unlike established procedures such as Dual-Energy X-ray Absorptiometry (DEXA), QUS assesses bone density using sound waves, providing a radiation-free, safe and effective alternative. This non-invasive method makes it ideal for application in a variety of healthcare settings, including community health programs and point-of-care diagnostics, where quick and convenient screening is required.
Application:
Osteoporosis segment is expected to dominate the global bone mineral densitometry (BMD) market share
The osteoporosis segment is expected to hold the dominant position in the global bone mineral densitometry (BMD) market share. Osteoporosis is a bone disease that develops when bone mineral density and bone mass decrease, or when the structure and strength of bone change. This can lead to a decrease in bone strength that can increase the risk of fractures (broken bones). The dominance of osteoporosis is due to the increasing incidence of osteoporosis. The high prevalence of osteoporosis decreases bone density and hence increases the demand for bone densitometers.
For instance, according to the Centers for Disease Control and Prevention (CDC), According to the total number of Americans over the age of 50, 12.6% have osteoporosis. This means that osteoporosis affects 12.6% of Americans over the age of fifty. According to estimates, osteoporosis affects 10 million Americans and around 75 million individuals across the United States, Europe, and Japan.
Fractures segment is the fastest growing segment in the global bone mineral densitometry (BMD) market share
The fractures segment is the fastest growing segment in the global bone mineral densitometry (BMD) market. This growth is driven by the growing incidence of fractures due to the increasing number of road accidents and injuries. The increasing incidence of fractures increases the demand for bone mineral densitometry to assess the condition of bone and increases the demand for bone densitometers.
For instance, according to the Ohio State University, 6 million people in the United States break a bone each year. Fractures account for 16% of all musculoskeletal injuries in the U.S. annually. More than 40% of fractures occur at home (22.5% inside and 19.1% outside). Approximately 887,679 hospitalizations result each year from fractures. For an instance, according to HealthInAging.org, Up to 300,000 older adults break their hips each year. Ninety percent of the time a fall causes these fractures. The risk of death is about 25 percent in the year after a hip fracture. One in four men and one in two women over age 50 will break a bone due to osteoporosis. This disease makes bones fragile. Osteoporosis affects people of all ethnic backgrounds. More than 2 million people in the United States have fractures related to osteoporosis.
Market Geographical Share
North America is expected to hold a significant position in the global bone mineral densitometry (BMD) market share
North America is expected to hold a significant portion of the global bone mineral densitometry (BMD) market. This is due to the increasing incidence of bone-related disorders, technological advancements, product renovations, and recent product launches in the region.
For instance, according to the Bone Health and Osteoporosis Foundation, approximately 10 million Americans have osteoporosis and another 44 million have low bone density, placing them at increased risk. 54 million Americans, half of all adults age 50 and older, are at risk of breaking a bone. One in two women and up to one in four men will break a bone in their lifetime due to osteoporosis. For women, the incidence is greater than that of heart attack, stroke, and breast cancer combined. Moreover, according to John Hopkins Medicine, 30% of Caucasian postmenopausal women in the United States have osteoporosis, while 54% have osteopenia. The incidence of deficient bone mass rises with age.
Moreover, according to the National Library of Medicine, every year, an estimated 1.5 million people suffer fractures as a result of bone disease. Hip osteoporosis affects around ten million people over the age of fifty in the United States. An additional 33.6 million people over the age of 50 have low bone mass, often known as "osteopenia" of the hip, putting them at risk for osteoporosis and associated problems later in life.
Asia Pacific is growing at the fastest pace in the global bone mineral densitometry (BMD) market
Asia Pacific is experiencing the fastest growth in global bone mineral densitometry (BMD) owing to the increasing incidence of bone-related disorders, technological advancements, and product renovations in the region. For instance, according to the National Institute of Health, as per the survey reports, 61 million individuals in India have osteoporosis, with women accounting for 80 percent of the cases. The peak prevalence of osteoporosis in India occurs 10-20 years earlier than in Western countries, putting a strain on both public health and the economy. In India, every third woman and every eighth man suffer from osteoporosis.
Market Competitive Landscape
The major global players in the global bone mineral densitometry (BMD) market include GE HealthCare, Hologic, Inc., BeamMed Inc., Echolight S.p.a, Medonica, Shenzhen XRAY Electric Co., Ltd., Osteosys Corp., Trivitron Healthcare, Eurotec Medical Systems s.r.l, Furuno Electric Co., Ltd among others.
Emerging Players
Bone Health Technologies, NXGN Management, LLC. among others
Metrics | Details | |
CAGR | XX% | |
Market Size Available for Years | 2022-2031 | |
Estimation Forecast Period | 2024-2031 | |
Revenue Units | Value (US$ Mn) | |
Segments Covered | Product Type | Axial Bone Densitometers, Peripheral Bone Densitometers |
Technology | Dual-energy X-ray Absorptiometry (DXA), Peripheral Dual-Energy X-Ray Absorptiometry, Quantitative Ultrasound, Quantitative Computed Tomography, Radiographic Absorptiometry, Others | |
Application | Osteoporosis, Osteopenia, Fractures, Rheumatoid Arthritis, Cystic Fibrosis, Chronic Kidney Diseases | |
End-User | Hospitals and Speciality Clinics, Diagnostic and Imaging Centers, Others | |
Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa | |
Key Developments
In February 2023, Echolight S.p.A. has recently established a collaboration with PRECCO, an organization dedicated to improving osteoporosis and fragility fracture prevention. Echolight's R.E.M.S. (Radiofrequency Echographic Multi Spectrometry) technology is at the the forefront of this project, offering a radiation-free way to examine bone density and microstructure. The collaboration is particularly significant since it aims to enhance access to sophisticated bone health examinations while emphasizing the importance of preventive actions in osteoporosis management.
Why Purchase the Report?
- To visualize the global bone mineral densitometry (BMD) market segmentation based on product type, technology, application, end-user, and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of global bone mineral densitometry (BMD) market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as Excel consisting of key products of all the major players.
The global bone mineral densitometry (BMD) market report would provide approximately 53 tables, 47 figures, and 176 pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
